SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-19-004373
Filing Date
2019-05-08
Accepted
2019-05-08 09:01:20
Documents
58
Period of Report
2019-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q zyne-20190331x10q.htm 10-Q 932225
2 EX-31.1 zyne-20190331ex311e43c17.htm EX-31.1 13556
3 EX-31.2 zyne-20190331ex3125c83a1.htm EX-31.2 13436
4 EX-32.1 zyne-20190331ex3219e0dca.htm EX-32.1 6142
5 EX-32.2 zyne-20190331ex3229e8b76.htm EX-32.2 6138
6 GRAPHIC zyne20190331x10q001.jpg GRAPHIC 150103
  Complete submission text file 0001558370-19-004373.txt   4282138

Data Files

Seq Description Document Type Size
7 EX-101.INS zyne-20190331.xml EX-101.INS 860969
8 EX-101.SCH zyne-20190331.xsd EX-101.SCH 31158
9 EX-101.CAL zyne-20190331_cal.xml EX-101.CAL 34337
10 EX-101.DEF zyne-20190331_def.xml EX-101.DEF 126051
11 EX-101.LAB zyne-20190331_lab.xml EX-101.LAB 275516
12 EX-101.PRE zyne-20190331_pre.xml EX-101.PRE 241004
Mailing Address 80 W. LANCASTER AVENUE SUITE 300 DEVON PA 19333
Business Address 80 W. LANCASTER AVENUE SUITE 300 DEVON PA 19333 484-581-7505
Zynerba Pharmaceuticals, Inc. (Filer) CIK: 0001621443 (see all company filings)

IRS No.: 260389433 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37526 | Film No.: 19805349
SIC: 2834 Pharmaceutical Preparations